BUZZ-Denali Therapeutics 推出 2 亿美元股票销售后下滑

路透中文
Dec 10, 2025
BUZZ-Denali <a href="https://laohu8.com/S/LENZ">Therapeutics</a> 推出 2 亿美元股票销售后下滑

12月9日 - ** 药物开发商Denali Therapeutics的DNLI.O股价在延时交易中下跌9%至17.90美元

** DNLI在 (link),公开发行价值2亿美元的股票和预先筹资的认股权证。

** 高盛(Goldman Sachs)、摩根大通证券(J.P. Morgan Securities)、摩根士丹利Morgan Stanley)和杰富瑞(Jefferies)是此次发行的联合簿记管理人。

** 募集资金将用于推进药物管线的商业准备和监管途径,扩大内部生产能力,以及其他用途

** 根据 (link) 招股说明书,截至 9 月 30 日,DNLI 有 1.466 亿股流通股。

** 覆盖该公司股票的所有 18 家券商均给予 "买入 "或更高评级;中位数 PT 为 32 美元--数据由 LSEG 编制

** 截至上次收盘,DNLI股价年累计下跌3.5%。

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10